CAL
Capital Advisors Ltd Portfolio holdings
AUM
$811M
1-Year Return
12.16%
This Quarter Return
-5.38%
1 Year Return
+12.16%
3 Year Return
+48.52%
5 Year Return
+80.47%
10 Year Return
+144.22%
AUM
$514M
AUM Growth
-$20.2M
(-3.8%)
Cap. Flow
+$8.4M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
39.86%
Holding
1,647
New
463
Increased
551
Reduced
193
Closed
170
Top Buys
| 1 |
Caesars Entertainment
CZR
|
+$5.19M |
| 2 |
Vanguard Large-Cap ETF
VV
|
+$1.47M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$949K |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$634K |
| 5 |
T. Rowe Price Dividend Growth ETF
TDVG
|
+$496K |
Top Sells
| 1 |
Bally's
BALY
|
+$5.8M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.78M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$936K |
| 4 |
ProShares Investment Grade-Interest Rate Hedged
IGHG
|
+$883K |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$271K |
Sector Composition
| 1 | Technology | 2.57% |
| 2 | Consumer Discretionary | 2.31% |
| 3 | Industrials | 1.49% |
| 4 | Healthcare | 1.36% |
| 5 | Financials | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Solid Biosciences
SLDB
$408M
| $1K | ﹤0.01% |
93
-31
| -25% | -$333 |
|
1002
SL Green Realty
SLG
$4.29B
| $1K | ﹤0.01% |
+34
| New | +$1K |
|
1003
Silgan Holdings
SLGN
$4.71B
| $1K | ﹤0.01% |
+29
| New | +$1K |
|
1004
SLM Corp
SLM
$6.01B
| $1K | ﹤0.01% |
+40
| New | +$1K |
|
1005
Snowflake
SNOW
$76.5B
| $1K | ﹤0.01% |
+6
| New | +$1K |
|
1006
Synovus
SNV
$7.13B
| $1K | ﹤0.01% |
+27
| New | +$1K |
|
1007
Sonoco
SON
$4.54B
| $1K | ﹤0.01% |
18
-7
| -28% | -$389 |
|
1008
Surmodics
SRDX
$459M
| $1K | ﹤0.01% |
+27
| New | +$1K |
|
1009
SS&C Technologies
SSNC
$21.6B
| $1K | ﹤0.01% |
+21
| New | +$1K |
|
1010
Shutterstock
SSTK
$715M
| $1K | ﹤0.01% |
11
+7
| +175% | +$636 |
|
1011
STAAR Surgical
STAA
$1.37B
| $1K | ﹤0.01% |
12
+4
| +50% | +$333 |
|
1012
Steris
STE
$24B
| $1K | ﹤0.01% |
8
+2
| +33% | +$250 |
|
1013
Takeda Pharmaceutical
TAK
$48.3B
| $1K | ﹤0.01% |
76
| – | – |
|
1014
Teradata
TDC
$1.99B
| $1K | ﹤0.01% |
23
| – | – |
|
1015
Bio-Techne
TECH
$7.93B
| $1K | ﹤0.01% |
16
+4
| +33% | +$250 |
|
1016
Terns Pharmaceuticals
TERN
$654M
| $1K | ﹤0.01% |
200
+98
| +96% | +$490 |
|
1017
Tenet Healthcare
THC
$16.9B
| $1K | ﹤0.01% |
13
+7
| +117% | +$538 |
|
1018
Tandem Diabetes Care
TNDM
$836M
| $1K | ﹤0.01% |
13
+10
| +333% | +$769 |
|
1019
Toll Brothers
TOL
$13.8B
| $1K | ﹤0.01% |
+20
| New | +$1K |
|
1020
Trex
TREX
$6.43B
| $1K | ﹤0.01% |
+18
| New | +$1K |
|
1021
Trimble
TRMB
$19.1B
| $1K | ﹤0.01% |
+24
| New | +$1K |
|
1022
TTEC Holdings
TTEC
$179M
| $1K | ﹤0.01% |
15
+6
| +67% | +$400 |
|
1023
Tetra Tech
TTEK
$9.37B
| $1K | ﹤0.01% |
40
+15
| +60% | +$375 |
|
1024
Tradeweb Markets
TW
$25.3B
| $1K | ﹤0.01% |
+11
| New | +$1K |
|
1025
10x Genomics
TXG
$1.57B
| $1K | ﹤0.01% |
+25
| New | +$1K |
|